Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2002 Nov;9(4):481-7.
doi: 10.1016/s1074-3804(05)60523-3.

Comparison of laparoscopic and conventional surgery in the treatment of early cervical cancer

Affiliations
Comparative Study

Comparison of laparoscopic and conventional surgery in the treatment of early cervical cancer

Chyi-Long Lee et al. J Am Assoc Gynecol Laparosc. 2002 Nov.

Abstract

Study objective: To compare efficacy, results, and complications of laparoscopic-assisted radical hysterectomy (LARH) and pelvic lymphadenectomy with abdominal radical hysterectomy (ARH) and pelvic lymphadenectomy in management of early (stages 1a2, 1b) invasive cervical carcinoma.

Design: Prospective cohort study (Canadian Task Force classification II-2).

Setting: University-affiliated hospital.

Patients: Sixty women enrolled for radical hysterectomy as most appropriate primary treatment.

Intervention: Radical hysterectomy performed by laparoscopy or laparotomy.

Measurements and main results: Thirty patients each underwent LARH and ARH. The groups did not differ in terms of age, weight, disease stage, operating time, and hospital stay. Mean blood loss was 962 +/- 543 ml for ARH and 450 +/- 284 ml for LARH. No laparoscopic procedure was converted to laparotomy. There was no significant difference in intraoperative and postoperative complications. There was no significant difference in recurrence rates.

Conclusion: LARH with pelvic lymphadenectomy does not increase recurrence rates and morbidity when performed by experienced endoscopists and oncologists.

PubMed Disclaimer

Publication types

MeSH terms